The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors. Research reported recently in the journal Nature ...

The Packard Center and ALS United will fund a preclinical study investigating how abnormal TDP-43 protein contributes to ALS.

New research has updated the understanding of how sugars, known as glycans, help immune cells move into the skin in the ...

Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...

Every cell in the body has the same DNA, but different cell types—such as muscle or brain cells—use different parts of it.

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...

The start of the trial marks an expansion of the firm's oncology pipeline, and the firm hopes mRNA-2808 will be the first of many T-cell engagers in its portfolio.

Thank you, operator. Good morning and good afternoon, everybody, and thank you for joining BioNTech's Third Quarter 2025 Earnings Call. As a reminder, the slides we'll use during the call and the ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the ...

Lumen Biosciences Brian Finrow breaks down Chinas biotech playbook and explores ways the U.S. can adapt it for its own continued success.